Yayın: Effects of simultaneous versus post exposure epigallocatechin-3-gallate treatment on aluminum induced neurotoxicity in rat hippocampus: A multi-approach study
| dc.contributor.author | Palabiyik-Yucelik, Saziye Sezin | |
| dc.contributor.author | Zeybek, Naciye Dilara | |
| dc.contributor.author | Cinar, Irfan | |
| dc.contributor.author | Akpinar, Erol | |
| dc.contributor.author | Zirh, Elham Bahador | |
| dc.contributor.author | Sipahi, Hande | |
| dc.contributor.author | Halici, Zekai | |
| dc.date.accessioned | 2026-01-06T06:06:32Z | |
| dc.date.issued | 2023-03-01 | |
| dc.description.abstract | Chronic aluminium(Al) exposure can affect the antioxidant and glutaminergic systems through N-methyl-D-aspartate receptors (NMDAR). This study was aimed to investigate the neurotoxic effect of Al through different mechanisms in rat hippocampus and to evaluate the protective role of epigallocatechin gallate (EGCG), a well-known antioxidant, with simultaneous administration of Al,as well as post-treatment after Al exposure.For this purpose, aluminum chloride(AlCl3) was administered simultaneously with two different EGCG doses for 8 weeks as the first part of the study.In the second part of the study, after 4 weeks of AlCl3 pre-administration, two different EGCG doses were also administered during four additional weeks as post-treatment.Al administration led to oxidative stress and increased acetylcholinesterase levels.NMDAR subunit mRNA expressions were down-regulated by Al, which was apparent in NMDAR1/2B subunits.Simultaneous EGCG treatment has shown a better neuroprotective effect in terms of these mechanisms and represents novel approach for the prevention of neurodegenerative diseases likely to be induced by Al. | |
| dc.description.uri | https://doi.org/10.1016/j.etap.2023.104061 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/36621558 | |
| dc.description.uri | https://hdl.handle.net/20.500.11851/10328 | |
| dc.description.uri | https://doi.org/10.1016/j.etap.2023.104061 10.1016/j.etap.2023.104061 | |
| dc.description.uri | https://avesis.atauni.edu.tr/publication/details/bc6f7e73-4227-49a2-a697-89cbadc409da/oai | |
| dc.description.uri | https://aperta.ulakbim.gov.tr/record/272148 | |
| dc.identifier.doi | 10.1016/j.etap.2023.104061 | |
| dc.identifier.issn | 1382-6689 | |
| dc.identifier.openaire | doi_dedup___::f228fb1356954e7f07233c4c1f0e3bce | |
| dc.identifier.orcid | 0000-0002-6239-6114 | |
| dc.identifier.orcid | 0000-0002-6161-5661 | |
| dc.identifier.orcid | 0000-0001-6482-3143 | |
| dc.identifier.pubmed | 36621558 | |
| dc.identifier.scopus | 2-s2.0-85145818894 | |
| dc.identifier.startpage | 104061 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/43906 | |
| dc.identifier.volume | 98 | |
| dc.identifier.wos | 000920582800001 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Environmental Toxicology and Pharmacology | |
| dc.rights | OPEN | |
| dc.subject | Assay | |
| dc.subject | Expression | |
| dc.subject | Diseases | |
| dc.subject | Stress | |
| dc.subject | Hippocampus | |
| dc.subject | Antioxidants | |
| dc.subject | Catechin | |
| dc.subject | Acetylcholinesterase Activity | |
| dc.subject | Neurotoxicity | |
| dc.subject | Acid | |
| dc.subject | Animals | |
| dc.subject | Rats, Wistar | |
| dc.subject | Inhibition | |
| dc.subject | Epigallocatechin gallate | |
| dc.subject | Rats | |
| dc.subject | NMDAR | |
| dc.subject | Nitric-Oxide | |
| dc.subject | Oxidative Stress | |
| dc.subject | Neuroprotective Agents | |
| dc.subject | Acetylcholinesterase | |
| dc.subject | Neurotoxicity Syndromes | |
| dc.subject | Aluminum | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Effects of simultaneous versus post exposure epigallocatechin-3-gallate treatment on aluminum induced neurotoxicity in rat hippocampus: A multi-approach study | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
